Neurofibromatosis Type 1: Modeling CNS Dysfunction

被引:60
|
作者
Gutmann, David H. [1 ]
Parada, Luis F. [2 ]
Silva, Alcino J. [3 ]
Ratner, Nancy [4 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源
JOURNAL OF NEUROSCIENCE | 2012年 / 32卷 / 41期
基金
美国国家卫生研究院;
关键词
CORPUS-CALLOSUM MORPHOLOGY; MOUSE MODEL; PROGENITOR PROLIFERATION; GLIOMA FORMATION; ABERRANT GROWTH; NF1; GENE; BRAIN; CHILDREN; PATHWAY; DIFFERENTIATION;
D O I
10.1523/JNEUROSCI.3242-12.2012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial neoplasms (optic gliomas, malignant astrocytomas) and neuronal dysfunction (learning disabilities, attention deficits). Nf1 genetically engineered mouse models have revealed the molecular and cellular underpinnings of gliomagenesis, attention deficit, and learning problems with relevance to basic neurobiology. Using NF1 as a model system, these studies have revealed critical roles for the NF1 gene in non-neoplastic cells in the tumor microenvironment, the importance of brain region heterogeneity, novel mechanisms of glial growth regulation, the neurochemical bases for attention deficit and learning abnormalities, and new insights into neural stem cell function. Here we review recent studies, presented at a symposium at the 2012 Society for Neuroscience annual meeting, that highlight unexpected cell biology insights into RAS and cAMP pathway effects on neural progenitor signaling, neuronal function, and oligodendrocyte lineage differentiation.
引用
收藏
页码:14087 / 14093
页数:7
相关论文
共 50 条
  • [1] Modeling cognitive dysfunction in neurofibromatosis-1
    Diggs-Andrews, Kelly A.
    Gutmann, David H.
    TRENDS IN NEUROSCIENCES, 2013, 36 (04) : 237 - 247
  • [2] Autonomic thermoregulatory dysfunction in neurofibromatosis type 1
    Madeira, Luciana G.
    Passos, Renata L. F.
    de Souza, Juliana F.
    Rezende, Nilton A.
    Rodrigues, Luiz O. C.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (10) : 796 - 802
  • [3] Neurocognitive dysfunction in children with neurofibromatosis type 1
    Tena L. Rosser
    Roger J. Packer
    Current Neurology and Neuroscience Reports, 2003, 3 (2) : 129 - 136
  • [4] CNS glial progenitors and schwann cells in neurofibromatosis Type 1
    Ratner, N
    Miller, SJ
    Ling, B
    Huang, YN
    Bennett, MR
    Mckinnon, R
    Rizvi, TA
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 2 - 2
  • [5] Multiple primary CNS tumors associated with neurofibromatosis type 1
    Lair, Lindsey L.
    Allen, Jeffrey
    NEUROLOGY, 2007, 68 (12) : A287 - A287
  • [6] Epilepsy in neurofibromatosis type 1: Diffuse cerebral dysfunction?
    Serdaroglu, Esra
    Konuskan, Bahadir
    Oguz, Kader Karli
    Gurler, Gokce
    Yalnizoglu, Dilek
    Anlar, Banu
    EPILEPSY & BEHAVIOR, 2019, 98 : 6 - 9
  • [7] Neuroretinal dysfunction in patients affected by neurofibromatosis type 1
    Moramarco, Antonietta
    Lucchino, Luca
    Mallone, Fabiana
    Marcelli, Michela
    Alisi, Ludovico
    Roberti, Vincenzo
    Giustini, Sandra
    Lambiase, Alessandro
    Nebbioso, Marcella
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (05) : 773 - 779
  • [8] Neuroretinal dysfunction in patients affected by neurofibromatosis type 1
    Antonietta Moramarco
    Luca Lucchino
    Fabiana Mallone
    Michela Marcelli
    Ludovico Alisi
    Vincenzo Roberti
    Sandra Giustini
    Alessandro Lambiase
    Marcella Nebbioso
    International Journal of Ophthalmology, 2022, 15 (05) : 773 - 779
  • [9] Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
    Rance, Gary
    Zanin, Julien
    Maier, Alice
    Chisari, Donella
    Haebich, Kristina M.
    North, Kathryn N.
    Dabscheck, Gabriel
    Seal, Marc L.
    Delatycki, Martin B.
    Payne, Jonathan M.
    JAMA NETWORK OPEN, 2021, 4 (12) : E2136842
  • [10] An update on the CNS manifestations of neurofibromatosis type 2
    Coy, Shannon
    Rashid, Rumana
    Stemmer-Rachamimov, Anat
    Santagata, Sandro
    ACTA NEUROPATHOLOGICA, 2020, 139 (04) : 643 - 665